1111 related articles for article (PubMed ID: 11093442)
1. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of autoantibodies against a-fodrin in serum, tear fluid, and saliva from patients with Sjögren's syndrome.
Yavuz S; Toker E; Bicakcigil M; Mumcu G; Cakir S
J Rheumatol; 2006 Jul; 33(7):1289-92. PubMed ID: 16821267
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity and specificity for primary Sjögren's syndrome of IgA and IgG anti-alpha-fodrin antibodies detected by ELISA.
Ruffatti A; Ostuni P; Grypiotis P; Botsios C; Tonello M; Grava C; Favaro M; Todesco S
J Rheumatol; 2004 Mar; 31(3):504-7. PubMed ID: 14994395
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of antibodies against alpha-fodrin in Sjögren's syndrome: comparison of 2 sets of classification criteria.
Witte T; Matthias T; Oppermann M; Helmke K; Peter HH; Schmidt RE; Tishler M
J Rheumatol; 2003 Oct; 30(10):2157-9. PubMed ID: 14528510
[TBL] [Abstract][Full Text] [Related]
5. The importance of alpha-fodrin antibodies in the diagnosis of Sjögren's syndrome.
Turkçapar N; Olmez U; Tutkak H; Duman M
Rheumatol Int; 2006 Feb; 26(4):354-9. PubMed ID: 15990993
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against alpha-fodrin in Sjögren's syndrome with neurological manifestations.
de Seze J; Dubucquoi S; Fauchais AL; Hachulla E; Matthias T; Lefranc D; Hatron PY; Vermersch P; Witte T
J Rheumatol; 2004 Mar; 31(3):500-3. PubMed ID: 14994394
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of IgG anti-{alpha}-fodrin antibodies in Sjogren's syndrome.
Ruiz-Tíscar JL; López-Longo FJ; Sánchez-Ramón S; Santamaría B; Urrea R; Carreño L; Estecha A; Vigil D; Fernández-Cruz E; Rodríguez-Mahou M
Ann N Y Acad Sci; 2005 Jun; 1050():210-6. PubMed ID: 16014536
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunological characteristics of patients with Sjögren's syndrome in relation to alpha-fodrin antibodies.
Willeke P; Gaubitz M; Schotte H; Becker H; Mickholz E; Domschke W; Schlüter B
Rheumatology (Oxford); 2007 Mar; 46(3):479-83. PubMed ID: 16935916
[TBL] [Abstract][Full Text] [Related]
9. Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.
Maeno N; Takei S; Imanaka H; Oda H; Yanagi K; Hayashi Y; Miyata K
J Rheumatol; 2001 Apr; 28(4):860-4. PubMed ID: 11327263
[TBL] [Abstract][Full Text] [Related]
10. Anti-alpha-fodrin autoantibody is an early diagnostic marker for childhood primary Sjögren's syndrome.
Kobayashi I; Kawamura N; Okano M; Shikano T; Mizumoto M; Hayashi Y; Kobayashi K
J Rheumatol; 2001 Feb; 28(2):363-5. PubMed ID: 11246678
[TBL] [Abstract][Full Text] [Related]
11. The epitope study of alpha-fodrin autoantibody in primary Sjögren's syndrome.
Chen Q; Li X; He W; Zhang H; Gao A; Cheng Y; Lei J; Li S; Zeng L
Clin Exp Immunol; 2007 Sep; 149(3):497-503. PubMed ID: 17614976
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to alpha-fodrin in primary Sjögren's syndrome and SLE detected by an in vitro transcription and translation assay.
Nordmark G; Rorsman F; Rönnblom L; Cajander S; Taussig MJ; Kämpe O; Winqvist O
Clin Exp Rheumatol; 2003; 21(1):49-56. PubMed ID: 12673889
[TBL] [Abstract][Full Text] [Related]
13. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome.
Lawind MF; Alyasky A; Elwan NM; Mourad H; Al-Bendary A
Egypt J Immunol; 2004; 11(1):75-81. PubMed ID: 15724389
[TBL] [Abstract][Full Text] [Related]
14. Epitope mapping of anti-alpha-fodrin autoantibody in juvenile Sjögren's syndrome: difference in major epitopes between primary and secondary cases.
Shiari R; Kobayashi I; Toita N; Hatano N; Kawamura N; Okano M; Hayashi Y; Kobayashi K; Ariga T
J Rheumatol; 2006 Jul; 33(7):1395-400. PubMed ID: 16821274
[TBL] [Abstract][Full Text] [Related]
15. Alpha-fodrin as a putative autoantigen in Graves' ophthalmopathy.
Kahaly GJ; Bang H; Berg W; Dittmar M
Clin Exp Immunol; 2005 Apr; 140(1):166-72. PubMed ID: 15762888
[TBL] [Abstract][Full Text] [Related]
16. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity and specificity of anti-alpha-fodrin antibodies in primary Sjögren's syndrome.
Szántó A; Csípo I; Zeher M
J Rheumatol; 2005 Jan; 32(1):197; author reply 197-8. PubMed ID: 15630756
[No Abstract] [Full Text] [Related]
20. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
